Pharmaceutical
China
Germany
Research
Production
Distribution
Partnership
Investment
M&A Advisory
Lazard
Full Credential Description
Huadong Medicine. China, Germany. Announced Date 27/02/2022. Closed Date 04/10/2022. Deal value: $119m. Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment. Industry: Huadong Medicine is primarily involved in the pharmaceutical industry, focusing on the research, development, production, and distribution of medications and medical products.